Global Urticaria Market
Размер рынка в млрд долларов США
CAGR :
% 
USD
3.73 Billion
USD
11.40 Billion
2024
2032
 Прогнозируемый период |
2025 –2032 |
 Размер рынка (базовый год) |
USD 3.73 Billion |
 Размер рынка (прогнозируемый год) |
USD 11.40 Billion |
 CAGR |
% |
| Основные игроки рынка |
|
Global Urticaria Market Segmentation, By Type (Acute Urticaria, Chronic Urticaria), Drug Class (Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2032
Urticaria Market Analysis
The global urticaria market is expected to witness significant growth during the mentioned forecast period. Rising markets and huge investment in R&D are the major factors that are responsible for the growth of this market. Growing cases of urticaria market also creates an opportunity for the pharmaceutical companies to develop novel therapies and promising pipeline drugs. COVID-19 also had a major impact on the market growth.
Urticaria Market Size
Global urticaria market size was valued at USD 3.73 billion in 2024 and is projected to reach USD 11.40 billion by 2032, with a CAGR of 15.00% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Urticaria Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Johnson & Johnson Private Limited (U.S.), Amneal Pharmaceuticals, Inc. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Novartis AG (Switzerland)., Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Dr. Reddy's Laboratories Ltd (India), Mylan N.V (U.S.) |
|
Market Opportunities |
|
Urticaria Market Definition
Urticaria are characterized as raised, swollen, itchy, and red plums that appear on the skin which can be of different sizes. It can be caused as a result of indoor as well as outdoor allergens reactions or certain infections.
Urticaria Market Dynamics
Drivers
- Patient Awareness
Increasing awareness of hypersensitivity is increasing the demand for the treatment of chronically induced urticaria. Patients are now more active about their health and are ready to seek medical advice early. Improving literacy rates play an important role in the general patient's perception of the treatment of chronically induced urticaria.
Opportunities
- Rising Incidence of Utricaria
High prevalence of urticaria is one of the boosting factors for the growth in the global chronic spontaneous urticaria market. As per the American Academy of Allergy, Asthma and Immunology, around 20% of the people are infected with chronic urticaria in the U.S.
- Advanced Clinical Research and Technological Advancement
The development of new targeted therapies such as omalizumab for the treatment of chronic urticaria is expected to drive the market in the near future. In Poland, a study of 1091 patients with chronic urticaria was conducted in 2019 to assess the epidemiological and clinical features of chronic urticaria. Chronic spontaneous urticaria has been reported to cause chronic urticaria about twice as likely as chronic inducible urticaria.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to perform the treatment methods could curb the growth of the global urticaria market over a forecast period.
- High Cost
The huge expenditure required for the treatment surely hamper the market growth.
This global urticaria market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global urticaria market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Urticaria Market Scope
The global urticaria market is segmented on the basis of type, drug class, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Acute Urticaria
- Chronic Urticaria
Drug Class
- Antihistamines
- Anti-inflammation Medications
- Antidepressants
- Monoclonal Antibodies
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Urticaria Market Regional Analysis
The global urticaria market is analyzed and market size insights and trends are provided by type, drug class, route of administration, end-user and distribution channel as referenced above.
The major countries covered in the global urticaria market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for Urticaria market due to the major leaders in R&D activities, unhealthy life-style such as consumption of alcohol.
Asia-Pacific dominates the market due to the large number of generic manufacturer, developing healthcare facilities, and rise in government initiatives.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Urticaria Market Share
The global urticaria market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global urticaria market
Urticaria Market Leaders Operating in the Market Are:
- Johnson & Johnson Private Limited (U.S.)
- Amneal Pharmaceuticals, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)
- Dr. Reddy's Laboratories Ltd (India)
- Mylan N.V (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
